APA

Mulé J. J., Yang J., Shu S. & Rosenberg S. A. (19860606). The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Mulé J J, Yang J, Shu S and Rosenberg S A. 19860606. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Mulé J. J., Yang J., Shu S. and Rosenberg S. A. (19860606). The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Mulé J J, Yang J, Shu S and Rosenberg S A. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. : Journal of immunology (Baltimore, Md. : 1950). 19860606.